The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Growth In Market Value Is Anticipated For The Antimicrobial Resistance (AMR) Genotyping Panels Market Between 2026 And 2030?
The antimicrobial resistance (AMR) genotyping panels market has experienced rapid expansion in recent years. This market is forecasted to expand from $1.45 billion in 2025 to $1.66 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.4%. Historically, this growth can be attributed to several factors including the increasing prevalence of antimicrobial resistance, a rise in hospital-acquired infections, the enhancement of molecular diagnostic capabilities, greater awareness of resistance monitoring, and the introduction of advanced genotyping technologies.
The antimicrobial resistance (amr) genotyping panels market size is projected to undergo substantial expansion in the upcoming years. It is expected to reach $2.81 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 14.1%. This projected growth throughout the forecast period stems from escalating investments in infectious disease diagnostics, an increasing need for rapid point-of-care testing, the broadening scope of genomic epidemiology programs, the progressive integration of amr data analytics, and an intensified regulatory emphasis on resistance surveillance. Significant developments anticipated during the forecast period involve a greater uptake of multiplex resistance detection panels, the expanding application of rapid molecular diagnostics, the increasing incorporation of genomic surveillance tools, the growth of hospital-based amr testing services, and an enhanced concentration on the timely identification of resistance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30196&type=smp
Which Significant Factors Are Encouraging Growth In The Antimicrobial Resistance (AMR) Genotyping Panels Market?
The escalating occurrence of antimicrobial-resistant infections is projected to stimulate the growth of the antimicrobial resistance (AMR) genotyping panels market in the foreseeable future. Antimicrobial-resistant infections are characterized as illnesses caused by microorganisms such as bacteria, viruses, fungi, or parasites that have evolved to withstand the effects of standard antimicrobial drugs, making them more difficult to treat. Key contributors to the increase in antimicrobial resistance include the overuse and misuse of antibiotics. These habits have quickened the development of resistant pathogens, thereby increasing the demand for AMR genotyping panels capable of rapidly identifying resistance genes and guiding specific antimicrobial treatment. For instance, according to the Centers for Disease Control and Prevention (CDC), over 2.8 million antimicrobial-resistant infections are reported annually in the US. Thus, the growing prevalence of antimicrobial-resistant infections is propelling the expansion of the antimicrobial resistance (AMR) genotyping panels market.
How Is The Antimicrobial Resistance (AMR) Genotyping Panels Market Structured Across Different Market Segments?
The antimicrobial resistance (amr) genotyping panels market covered in this report is segmented –
1) By Product Type: Custom Panels, Pre-Designed Panels
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Microarray-Based, Next-Generation Sequencing (NSG)-Based, Other Technologies
3) By Application: Clinical Diagnostics, Research, Drug Development, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-users
Subsegments:
1) By Custom Panels: Pathogen-Specific Panels, Resistance Gene-Focused Panels, Multiplex Detection Panels, Targeted Mutation Panels, Research Application Panels
2) By Pre-Designed Panels: Standardized Diagnostic Panels, Broad-Spectrum Resistance Panels, Disease-Specific Panels, Commercially Validated Panels, Ready-To-Use Screening Panels
What Trends Are Shaping The Antimicrobial Resistance (AMR) Genotyping Panels Market Structure?
Leading companies active in the antimicrobial resistance (AMR) genotyping panels market are prioritizing the creation of advanced solutions, including multiplex PCR-based research assays, to enable the concurrent detection of numerous pathogens and antibiotic resistance genes in a single test. This approach enhances research productivity and facilitates quicker identification of emerging resistance patterns. Multiplex PCR-based research assays are defined as molecular tests designed to amplify and discern multiple genetic targets simultaneously for identifying pathogens and antibiotic resistance genes within a singular reaction. An illustrative example is the September 2025 introduction by Molecular Designs, a US-based company specializing in molecular diagnostics and research assays, of its Urogenital Microbiota with ABX 53 Simplicity Panel. This panel functions as a multiplex PCR-based research assay aimed at identifying urinary pathogens and antibiotic resistance genes within a singular test. It allows for the concurrent discovery of 28 urogenital and urinary microbial targets (comprising 20 bacterial, 7 fungal, and 1 protozoan strains) alongside 25 antibiotic-resistance gene markers. The product provides a same-day turnaround and is offered in both 96-well and 384-well plate configurations, with the 96-well option incorporating breakaway panels to minimize material waste.
Who Are The Key Market Participants In The Antimicrobial Resistance (AMR) Genotyping Panels Market?
Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.
Access The Complete Antimicrobial Resistance (AMR) Genotyping Panels Market Report:
Which Region Leads The Antimicrobial Resistance (AMR) Genotyping Panels Market By Size?
North America was the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance (amr) genotyping panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Antimicrobial Resistance (AMR) Genotyping Panels Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=30196&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Resistance (AMR) Genotyping Panels Market 2026, By The Business Research Company
Biomaterial Wound Dressing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biomaterial-wound-dressing-global-market-report
Preoperative Infection Prevention And Wound Cleansing Devices Global Market Report 2026
Topical Wound Agents Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/topical-wound-agents-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model